170

Hepatobiliary&Pancreas Surgery
Focuses on the health of liver, bile, and pancreatic organs.
Sub Categories on Hepatobiliary&Pancreas Surgery
Latest Articles
How protein protects against fatty liver

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease
Liver cancer and severe liver disease found to be more common if a close relative has fatty liver disease

Liver cancer and severe liver disease found to be more common if a close relative has fatty liver disease

by Karolinska InstitutetGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.08.018Close relatives of people with metabolic-associated fatty liver disease

Liver cancer and severe liver disease found to be more common if a close relative has fatty liver disease

by Karolinska InstitutetGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.08.018Close relatives of people with metabolic-associated fatty liver disease
Everything to Know About Alcoholic Liver Disease

Everything to Know About Alcoholic Liver Disease

Everything to Know About Alcoholic Liver DiseaseByCory MartinUpdated on December 19, 2023Medically reviewed byJay N. Yepuri, MDAlcoholic liver disease (ALD) is caused by excess

Everything to Know About Alcoholic Liver Disease

Everything to Know About Alcoholic Liver DiseaseByCory MartinUpdated on December 19, 2023Medically reviewed byJay N. Yepuri, MDAlcoholic liver disease (ALD) is caused by excess
Assessing the mechanisms for liver fibrosis

Assessing the mechanisms for liver fibrosis

by First Hospital of Jilin UniversityHepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. Credit: Wajahat MehalChro

Assessing the mechanisms for liver fibrosis

by First Hospital of Jilin UniversityHepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. Credit: Wajahat MehalChro
Research team explores etiologies of splenic venous hypertension

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea
Overcoming barriers to conducting clinical trials in childhood rare disease research

Overcoming barriers to conducting clinical trials in childhood rare disease research

FEBRUARY 29, 2024byThe Hospital for Sick ChildrenGraphical abstract. Credit:Hepatology(2023). DOI: 10.1097/HEP.0000000000000727Using a novel methodology, researchers at The Hospital

Overcoming barriers to conducting clinical trials in childhood rare disease research

FEBRUARY 29, 2024byThe Hospital for Sick ChildrenGraphical abstract. Credit:Hepatology(2023). DOI: 10.1097/HEP.0000000000000727Using a novel methodology, researchers at The Hospital
Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

by Elana GotkineFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, accordi

Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

by Elana GotkineFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, accordi
Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes
How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp
Novel pathway could lead to potential treatment for metabolic liver disease

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103
Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo